+918421517810
+442921251543
+918421517810
+442921251543
Dynamics in Post-pandemic Global Oncology Biosimilars Industry: Supply and Demand, Markets and Prices 2021-2027
Type: PDF
Status: Published
Categories: Aerospace and Defence
Report Code : OTHER2111121
No. of Pages : 132
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Oncology Biosimilars market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Oncology Biosimilars market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Monoclonal Antibody
Hematopoietic Agents
G-CSF
Others
Segmented by End User/Segment
Retail Pharmacies
Hospital Pharmacy
Online Pharmacy
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Teva Pharmaceutical Industries Ltd
STADA Arzneimittel AG
Sandoz International
Pfizer
Intas Pharmaceuticals
Dr. Reddy’s Laboratories
Celltrion
Biocon
BIOCAD
Apotex
List of Figures
Figure Oncology Biosimilars Picture
Figure Global Oncology Biosimilars Sales Volume and Growth Rate (2016-2027)
Figure Global Oncology Biosimilars Sales Value and Growth Rate (2016-2027)
Figure Global Oncology Biosimilars Sales Value CAGR (2020-2027) by Region
Figure Global Oncology Biosimilars Sales Volume Market Share by Company, 2020
Figure Global Oncology Biosimilars Sales Value Market Share by Company, 2020
Figure Global Oncology Biosimilars Sales Value and Growth Rate (2016-2027)
Figure Product Picture of Monoclonal Antibody
Figure Product Picture of Hematopoietic Agents
Figure Product Picture of G-CSF
Figure Product Picture of Others
Figure Global Oncology Biosimilars Sales Volume Market Share by Category, 2020
Figure Global Oncology Biosimilars Sales Value Market Share by Category, 2020
Figure North America Oncology Biosimilars Sales Volume Market Share by Category, 2020
Figure Europe Oncology Biosimilars Sales Volume Market Share by Category, 2020
Figure Asia Pacific Oncology Biosimilars Sales Volume Market Share by Category, 2020
Figure Central & South America Oncology Biosimilars Sales Volume Market Share by Category, 2020
Figure Middle East & Africa Oncology Biosimilars Sales Volume Market Share by Category, 2020
Figure Oncology Biosimilars in Retail Pharmacies
Figure Global Oncology Biosimilars Market: Retail Pharmacies (2016-2021)
Figure Oncology Biosimilars in Hospital Pharmacy
Figure Global Oncology Biosimilars Market: Hospital Pharmacy (2016-2021)
Figure Oncology Biosimilars in Online Pharmacy
Figure Global Oncology Biosimilars Market: Online Pharmacy (2016-2021)
Figure Global Oncology Biosimilars Sales Volume Market Share by End User/Segment, 2020
Figure Global Oncology Biosimilars Sales Value Market Share by End User/Segment, 2020
Figure North America Oncology Biosimilars Sales Volume Market Share by End User/Segment, 2020
Figure Europe Oncology Biosimilars Sales Volume Market Share by End User/Segment, 2020
Figure Asia Pacific Oncology Biosimilars Sales Volume Market Share by End User/Segment, 2020
Figure Central & South America Oncology Biosimilars Sales Volume Market Share by End User/Segment, 2020
Figure Middle East & Africa Oncology Biosimilars Sales Volume Market Share by End User/Segment, 2020
Figure Global Oncology Biosimilars Sales Volume Market Share by Region (2016-2021)
Figure Global Oncology Biosimilars Sales Value Market Share by Region (2016-2021)
Figure North America Oncology Biosimilars Sales Volume Status (2016-2021)
Figure North America Oncology Biosimilars Sales Value Status (2016-2021)
Figure Europe Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Europe Oncology Biosimilars Sales Value Status (2016-2021)
Figure Asia Pacific Oncology Biosimilars Sales Volume Status (2016-2021)
Figure North America Oncology Biosimilars Sales Value Status (2016-2021)
Figure Central & South America Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Europe Oncology Biosimilars Sales Value Status (2016-2021)
Figure Middle East & Africa Oncology Biosimilars Sales Volume Status (2016-2021)
Figure China Oncology Biosimilars Sales Value Status (2016-2021)
Figure North America Oncology Biosimilars Sales Volume Market Share by Country, 2020
Figure Japan Oncology Biosimilars Sales Value Status (2016-2021)
Figure United States Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Asia Other Oncology Biosimilars Sales Value Status (2016-2021)
Figure Canada Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Canada Oncology Biosimilars Sales Value Status (2016-2021)
Figure Mexico Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Mexico Oncology Biosimilars Sales Value Status (2016-2021)
Figure Europe Oncology Biosimilars Sales Volume Market Share by Country, 2020
Figure Europe Oncology Biosimilars Value Market Share by Country, 2020
Figure Germany Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Germany Oncology Biosimilars Sales Value Status (2016-2021)
Figure France Oncology Biosimilars Sales Volume Status (2016-2021)
Figure France Oncology Biosimilars Sales Value Status (2016-2021)
Figure UK Oncology Biosimilars Sales Volume Status (2016-2021)
Figure UK Oncology Biosimilars Sales Value Status (2016-2021)
Figure Italy Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Italy Oncology Biosimilars Sales Value Status (2016-2021)
Figure Russia Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Russia Oncology Biosimilars Sales Value Status (2016-2021)
Figure Spain Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Spain Oncology Biosimilars Sales Value Status (2016-2021)
Figure Asia Pacific Oncology Biosimilars Sales Volume Market Share by Country, 2020
Figure Asia Pacific Oncology Biosimilars Value Market Share by Country, 2020
Figure China Oncology Biosimilars Sales Volume Status (2016-2021)
Figure China Oncology Biosimilars Sales Value Status (2016-2021)
Figure Japan Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Japan Oncology Biosimilars Sales Value Status (2016-2021)
Figure Korea Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Korea Oncology Biosimilars Sales Value Status (2016-2021)
Figure Southeast Asia Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Southeast Asia Oncology Biosimilars Sales Value Status (2016-2021)
Figure India Oncology Biosimilars Sales Volume Status (2016-2021)
Figure India Oncology Biosimilars Sales Value Status (2016-2021)
Figure Australasia Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Australasia Oncology Biosimilars Sales Value Status (2016-2021)
Figure Central & South America Oncology Biosimilars Sales Volume Market Share by Country, 2020
Figure Central & South America Oncology Biosimilars Sales Value Market Share by Country, 2020
Figure Brazil Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Brazil Oncology Biosimilars Sales Value Status (2016-2021)
Figure Argentina Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Argentina Oncology Biosimilars Sales Value Status (2016-2021)
Figure Colombia Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Colombia Oncology Biosimilars Sales Value Status (2016-2021)
Figure Middle East & Africa Oncology Biosimilars Sales Volume Market Share by Country, 2020
Figure Middle East & Africa Oncology Biosimilars Value Market Share by Country, 2020
Figure Iran Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Iran Oncology Biosimilars Sales Value Status (2016-2021)
Figure South Africa Oncology Biosimilars Sales Volume Status (2016-2021)
Figure South Africa Oncology Biosimilars Sales Value Status (2016-2021)
Figure Israel Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Israel Oncology Biosimilars Sales Value Status (2016-2021)
Figure Turkey Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Turkey Oncology Biosimilars Sales Value Status (2016-2021)
Figure Saudi Arabia Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Saudi Arabia Oncology Biosimilars Sales Value Status (2016-2021)
Figure Oncology Biosimilars Supply Chain Analysis
Figure Oncology Biosimilars Production Process Chart Analysis
Figure Oncology Biosimilars Manufacturing Cost Analysis
Figure Global Oncology Biosimilars Sales Volume Forecast (2022-2027)
Figure Global Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure North America Oncology Biosimilars Sales Volume Forecast (2022-2027)
Figure North America Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure Global Oncology Biosimilars Sales Value Growth Rate Forecast (2022-2027)
Figure Europe Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure Asia Pacific Oncology Biosimilars Sales Volume Forecast (2022-2027)
Figure North America Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure Central & South America Oncology Biosimilars Sales Volume Forecast (2022-2027)
Figure Europe Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure Middle East & Africa Oncology Biosimilars Sales Volume Forecast (2022-2027)
Figure China Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure Japan Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure Asia Other Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure STADA Arzneimittel AG Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure STADA Arzneimittel AG Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure Sandoz International Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Sandoz International Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure Pfizer Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Pfizer Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure Intas Pharmaceuticals Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Intas Pharmaceuticals Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure Dr. Reddy’s Laboratories Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Dr. Reddy’s Laboratories Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure Celltrion Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Celltrion Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure Biocon Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Biocon Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure BIOCAD Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure BIOCAD Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure Apotex Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Apotex Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure Oncology Biosimilars Picture
Figure Global Oncology Biosimilars Sales Volume and Growth Rate (2016-2027)
Figure Global Oncology Biosimilars Sales Value and Growth Rate (2016-2027)
Figure Global Oncology Biosimilars Sales Value CAGR (2020-2027) by Region
Figure Global Oncology Biosimilars Sales Volume Market Share by Company, 2020
Figure Global Oncology Biosimilars Sales Value Market Share by Company, 2020
Figure Global Oncology Biosimilars Sales Value and Growth Rate (2016-2027)
Figure Product Picture of Monoclonal Antibody
Figure Product Picture of Hematopoietic Agents
Figure Product Picture of G-CSF
Figure Product Picture of Others
Figure Global Oncology Biosimilars Sales Volume Market Share by Category, 2020
Figure Global Oncology Biosimilars Sales Value Market Share by Category, 2020
Figure North America Oncology Biosimilars Sales Volume Market Share by Category, 2020
Figure Europe Oncology Biosimilars Sales Volume Market Share by Category, 2020
Figure Asia Pacific Oncology Biosimilars Sales Volume Market Share by Category, 2020
Figure Central & South America Oncology Biosimilars Sales Volume Market Share by Category, 2020
Figure Middle East & Africa Oncology Biosimilars Sales Volume Market Share by Category, 2020
Figure Oncology Biosimilars in Retail Pharmacies
Figure Global Oncology Biosimilars Market: Retail Pharmacies (2016-2021)
Figure Oncology Biosimilars in Hospital Pharmacy
Figure Global Oncology Biosimilars Market: Hospital Pharmacy (2016-2021)
Figure Oncology Biosimilars in Online Pharmacy
Figure Global Oncology Biosimilars Market: Online Pharmacy (2016-2021)
Figure Global Oncology Biosimilars Sales Volume Market Share by End User/Segment, 2020
Figure Global Oncology Biosimilars Sales Value Market Share by End User/Segment, 2020
Figure North America Oncology Biosimilars Sales Volume Market Share by End User/Segment, 2020
Figure Europe Oncology Biosimilars Sales Volume Market Share by End User/Segment, 2020
Figure Asia Pacific Oncology Biosimilars Sales Volume Market Share by End User/Segment, 2020
Figure Central & South America Oncology Biosimilars Sales Volume Market Share by End User/Segment, 2020
Figure Middle East & Africa Oncology Biosimilars Sales Volume Market Share by End User/Segment, 2020
Figure Global Oncology Biosimilars Sales Volume Market Share by Region (2016-2021)
Figure Global Oncology Biosimilars Sales Value Market Share by Region (2016-2021)
Figure North America Oncology Biosimilars Sales Volume Status (2016-2021)
Figure North America Oncology Biosimilars Sales Value Status (2016-2021)
Figure Europe Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Europe Oncology Biosimilars Sales Value Status (2016-2021)
Figure Asia Pacific Oncology Biosimilars Sales Volume Status (2016-2021)
Figure North America Oncology Biosimilars Sales Value Status (2016-2021)
Figure Central & South America Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Europe Oncology Biosimilars Sales Value Status (2016-2021)
Figure Middle East & Africa Oncology Biosimilars Sales Volume Status (2016-2021)
Figure China Oncology Biosimilars Sales Value Status (2016-2021)
Figure North America Oncology Biosimilars Sales Volume Market Share by Country, 2020
Figure Japan Oncology Biosimilars Sales Value Status (2016-2021)
Figure United States Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Asia Other Oncology Biosimilars Sales Value Status (2016-2021)
Figure Canada Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Canada Oncology Biosimilars Sales Value Status (2016-2021)
Figure Mexico Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Mexico Oncology Biosimilars Sales Value Status (2016-2021)
Figure Europe Oncology Biosimilars Sales Volume Market Share by Country, 2020
Figure Europe Oncology Biosimilars Value Market Share by Country, 2020
Figure Germany Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Germany Oncology Biosimilars Sales Value Status (2016-2021)
Figure France Oncology Biosimilars Sales Volume Status (2016-2021)
Figure France Oncology Biosimilars Sales Value Status (2016-2021)
Figure UK Oncology Biosimilars Sales Volume Status (2016-2021)
Figure UK Oncology Biosimilars Sales Value Status (2016-2021)
Figure Italy Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Italy Oncology Biosimilars Sales Value Status (2016-2021)
Figure Russia Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Russia Oncology Biosimilars Sales Value Status (2016-2021)
Figure Spain Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Spain Oncology Biosimilars Sales Value Status (2016-2021)
Figure Asia Pacific Oncology Biosimilars Sales Volume Market Share by Country, 2020
Figure Asia Pacific Oncology Biosimilars Value Market Share by Country, 2020
Figure China Oncology Biosimilars Sales Volume Status (2016-2021)
Figure China Oncology Biosimilars Sales Value Status (2016-2021)
Figure Japan Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Japan Oncology Biosimilars Sales Value Status (2016-2021)
Figure Korea Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Korea Oncology Biosimilars Sales Value Status (2016-2021)
Figure Southeast Asia Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Southeast Asia Oncology Biosimilars Sales Value Status (2016-2021)
Figure India Oncology Biosimilars Sales Volume Status (2016-2021)
Figure India Oncology Biosimilars Sales Value Status (2016-2021)
Figure Australasia Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Australasia Oncology Biosimilars Sales Value Status (2016-2021)
Figure Central & South America Oncology Biosimilars Sales Volume Market Share by Country, 2020
Figure Central & South America Oncology Biosimilars Sales Value Market Share by Country, 2020
Figure Brazil Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Brazil Oncology Biosimilars Sales Value Status (2016-2021)
Figure Argentina Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Argentina Oncology Biosimilars Sales Value Status (2016-2021)
Figure Colombia Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Colombia Oncology Biosimilars Sales Value Status (2016-2021)
Figure Middle East & Africa Oncology Biosimilars Sales Volume Market Share by Country, 2020
Figure Middle East & Africa Oncology Biosimilars Value Market Share by Country, 2020
Figure Iran Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Iran Oncology Biosimilars Sales Value Status (2016-2021)
Figure South Africa Oncology Biosimilars Sales Volume Status (2016-2021)
Figure South Africa Oncology Biosimilars Sales Value Status (2016-2021)
Figure Israel Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Israel Oncology Biosimilars Sales Value Status (2016-2021)
Figure Turkey Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Turkey Oncology Biosimilars Sales Value Status (2016-2021)
Figure Saudi Arabia Oncology Biosimilars Sales Volume Status (2016-2021)
Figure Saudi Arabia Oncology Biosimilars Sales Value Status (2016-2021)
Figure Oncology Biosimilars Supply Chain Analysis
Figure Oncology Biosimilars Production Process Chart Analysis
Figure Oncology Biosimilars Manufacturing Cost Analysis
Figure Global Oncology Biosimilars Sales Volume Forecast (2022-2027)
Figure Global Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure North America Oncology Biosimilars Sales Volume Forecast (2022-2027)
Figure North America Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure Global Oncology Biosimilars Sales Value Growth Rate Forecast (2022-2027)
Figure Europe Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure Asia Pacific Oncology Biosimilars Sales Volume Forecast (2022-2027)
Figure North America Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure Central & South America Oncology Biosimilars Sales Volume Forecast (2022-2027)
Figure Europe Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure Middle East & Africa Oncology Biosimilars Sales Volume Forecast (2022-2027)
Figure China Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure Japan Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure Asia Other Oncology Biosimilars Sales Value Forecast (2022-2027)
Figure Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure STADA Arzneimittel AG Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure STADA Arzneimittel AG Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure Sandoz International Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Sandoz International Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure Pfizer Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Pfizer Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure Intas Pharmaceuticals Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Intas Pharmaceuticals Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure Dr. Reddy’s Laboratories Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Dr. Reddy’s Laboratories Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure Celltrion Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Celltrion Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure Biocon Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Biocon Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure BIOCAD Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure BIOCAD Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Figure Apotex Oncology Biosimilars Sales Volume Market Share Globally (2019-2021)
Figure Apotex Oncology Biosimilars Sales Value Market Share Globally (2019-2021)
Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Oncology Biosimilars Market Status and Forecast (2016-2027) 1.3.2 Global Oncology Biosimilars Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Oncology Biosimilars Supply by Company 2.1 Global Oncology Biosimilars Sales Volume by Company 2.2 Global Oncology Biosimilars Sales Value by Company 2.3 Global Oncology Biosimilars Price by Company 2.4 Oncology Biosimilars Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate3 Global and Regional Oncology Biosimilars Market Status by Category 3.1 Oncology Biosimilars Category Introduction 3.1.1 Monoclonal Antibody 3.1.2 Hematopoietic Agents 3.1.3 G-CSF 3.1.4 Others 3.2 Global Oncology Biosimilars Market by Category 3.2.1 Global Oncology Biosimilars Sales Volume by Category (2016-2021) 3.2.2 Global Oncology Biosimilars Sales Value by Category (2016-2021) 3.2.3 Global Oncology Biosimilars Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Oncology Biosimilars Market Status by End User/Segment 4.1 Oncology Biosimilars Segment by End User/Segment 4.1.1 Retail Pharmacies 4.1.2 Hospital Pharmacy 4.1.3 Online Pharmacy 4.2 Global Oncology Biosimilars Market by End User/Segment 4.2.1 Global Oncology Biosimilars Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Oncology Biosimilars Sales Value by End User/Segment (2016-2021) 4.2.3 Global Oncology Biosimilars Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Oncology Biosimilars Market Status by Region 5.1 Global Oncology Biosimilars Market by Region 5.1.1 Global Oncology Biosimilars Sales Volume by Region 5.1.2 Global Oncology Biosimilars Sales Value by Region 5.2 North America Oncology Biosimilars Market Status 5.3 Europe Oncology Biosimilars Market Status 5.4 Asia Pacific Oncology Biosimilars Market Status 5.5 Central & South America Oncology Biosimilars Market Status 5.6 Middle East & Africa Oncology Biosimilars Market Status6 North America Oncology Biosimilars Market Status 6.1 North America Oncology Biosimilars Market by Country 6.1.1 North America Oncology Biosimilars Sales Volume by Country (2016-2021) 6.1.2 North America Oncology Biosimilars Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Oncology Biosimilars Market Status 7.1 Europe Oncology Biosimilars Market by Country 7.1.1 Europe Oncology Biosimilars Sales Volume by Country (2016-2021) 7.1.2 Europe Oncology Biosimilars Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Oncology Biosimilars Market Status 8.1 Asia Pacific Oncology Biosimilars Market by Country 8.1.1 Asia Pacific Oncology Biosimilars Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Oncology Biosimilars Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Oncology Biosimilars Market Status 9.1 Central & South America Oncology Biosimilars Market by Country 9.1.1 Central & South America Oncology Biosimilars Sales Volume by Country (2016-2021) 9.1.2 Central & South America Oncology Biosimilars Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Oncology Biosimilars Market Status 10.1 Middle East & Africa Oncology Biosimilars Market by Country 10.1.1 Middle East & Africa Oncology Biosimilars Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Oncology Biosimilars Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Oncology Biosimilars Manufacturing Cost Analysis 11.5 Oncology Biosimilars Sales Channel and Distributors Analysis 11.5.1 Oncology Biosimilars Sales Channel 11.5.2 Oncology Biosimilars Distributors 11.6 Oncology Biosimilars Downstream Major Buyers12 Global Oncology Biosimilars Market Forecast by Category and by End User/Segment 12.1 Global Oncology Biosimilars Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Oncology Biosimilars Forecast by Category 12.2.1 Global Oncology Biosimilars Sales Volume Forecast by Category 12.2.2 Global Oncology Biosimilars Sales Value Forecast by Category 12.2.3 Global Oncology Biosimilars Price Forecast by Category 12.3 Global Oncology Biosimilars Forecast by End User/Segment 12.3.1 Global Oncology Biosimilars Sales Volume Forecast by End User/Segment 12.3.2 Global Oncology Biosimilars Sales Value Forecast by End User/Segment 12.3.3 Global Oncology Biosimilars Price Forecast by End User/Segment13 Global Oncology Biosimilars Market Forecast by Region/Country 13.1 Global Oncology Biosimilars Market Forecast by Region (2022-2027) 13.1.1 Global Oncology Biosimilars Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Oncology Biosimilars Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Teva Pharmaceutical Industries Ltd 14.1.1 Company Information 14.1.2 Oncology Biosimilars Product Introduction 14.1.3 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 STADA Arzneimittel AG 14.2.1 Company Information 14.2.2 Oncology Biosimilars Product Introduction 14.2.3 STADA Arzneimittel AG Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Sandoz International 14.3.1 Company Information 14.3.2 Oncology Biosimilars Product Introduction 14.3.3 Sandoz International Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Pfizer 14.4.1 Company Information 14.4.2 Oncology Biosimilars Product Introduction 14.4.3 Pfizer Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Intas Pharmaceuticals 14.5.1 Company Information 14.5.2 Oncology Biosimilars Product Introduction 14.5.3 Intas Pharmaceuticals Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Dr. Reddy’s Laboratories 14.6.1 Company Information 14.6.2 Oncology Biosimilars Product Introduction 14.6.3 Dr. Reddy’s Laboratories Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Celltrion 14.7.1 Company Information 14.7.2 Oncology Biosimilars Product Introduction 14.7.3 Celltrion Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 Biocon 14.8.1 Company Information 14.8.2 Oncology Biosimilars Product Introduction 14.8.3 Biocon Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 BIOCAD 14.9.1 Company Information 14.9.2 Oncology Biosimilars Product Introduction 14.9.3 BIOCAD Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 Apotex 14.10.1 Company Information 14.10.2 Oncology Biosimilars Product Introduction 14.10.3 Apotex Oncology Biosimilars Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis15 Conclusion16 Methodology
Request For Request Sample
Published On: 04-12-21
Single User
US$ 2980*** Benefits ***
1. 15% Free customization
2. Two Countries can add as per your choice
3. Two Company can add as per your choice
4. 35+ Countries
*** Services ***
1. Quarterly Industry Update for Six Months
2. One personal Research Analyst Allocate to you
3. 24*7 Research Support
4. Query will be resolve with 48 hours
Multi User
US$ 4470*** Benefits ***
1. 25% Free customization
2. Excel Data Sheet
3. Two Countries can add as per your choice
4. Two Company can add as per your choice
35+ Countries
*** Services ***
1. Client will get one updated report for a year.
2. Quarterly Industry Update for 1 Year.
3. One research analyst will allocate to you.
4. Query will be resolved within 36 hours.
24*7 Research Support.
Corporate User
US$ 5960*** Benefits ***
1. 25% Free customization
2. Excel Data Sheet
3. Two Countries can add as per your choice
4. Two Company can add as per your choice
5. 35+ Countries
*** Services ***
1. Client will get one updated report for a year.
2. Quarterly Industry Update for 1 Year.
3. One research analyst will allocate to you.
4. Query will be resolved within 36 hours.
5. 24*7 Research Support.
INDUSTRIES
Aerospace and Defence Agriculture Automotive Services Consumer Goods Energy and Power Food And Beverages Industry Services IT And Telecommunications Manufacturing and Construction Chemicals And Materials Medical Devices Healthcare And Pharmaceuticals Semiconductor And ElectronicsQUICK LINKS
About Us Press Releases Blogs Become a Reseller Privacy Policy Disclaimer Terms and Conditions Sitemap
